Skip to main content
Erschienen in: European Radiology 5/2016

29.07.2015 | Magnetic Resonance

Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study

verfasst von: Maximilian Merz, Thomas M. Moehler, Judith Ritsch, Tobias Bäuerle, Christian M. Zechmann, Barbara Wagner, Anna Jauch, Dirk Hose, Christina Kunz, Thomas Hielscher, Hendrik Laue, Hartmut Goldschmidt, Stefan Delorme, Jens Hillengass

Erschienen in: European Radiology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Aim of this prospective study was to investigate prognostic significance of increased bone marrow microcirculation as detected by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for survival and local complications in patients with multiple myeloma (MM).

Methods

We performed DCE-MRI of the lumbar spine in 131 patients with newly diagnosed MM and analysed data according to the Brix model to acquire amplitude A and exchange rate constant k ep. In 61 patients a second MRI performed after therapy was evaluated to assess changes in vertebral height and identify vertebral fractures.

Results

Correlation analysis revealed significant positive association between beta2-microglobulin as well as immunoparesis with DCE-MRI parameters A and k ep. Additionally, A was negatively correlated with haemoglobin levels and k ep was positively correlated with LDH levels. Higher baseline k ep values were associated with decreased vertebral height in a second MRI (P = 0.007) and A values were associated with new vertebral fractures in the lower lumbar spine (P = 0.03 for L4). Pre-existing lytic bone lesions or remission after therapy had no impact on the occurrence of vertebral fractures. Multivariate analysis revealed that amplitude A is an independent adverse risk factor for overall survival.

Conclusion

DCE-MRI is a non-invasive tool with significance for systemic prognosis and vertebral complications.

Key Points

Qualitative parameters from DCE-MRI are correlated with established factors of disease activity
Increased marrow microcirculation might be a risk factor for loss of vertebral height and fractures
Amplitude A is an independent predictor for shortened overall survival
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Engelhardt M, Terpos E, Kleber M et al (2014) European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica 99:232–242CrossRefPubMedPubMedCentral Engelhardt M, Terpos E, Kleber M et al (2014) European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica 99:232–242CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Chng WJ, Dispenzieri A, Chim CS et al (2014) IMWG consensus on risk stratification in multiple myeloma. Leukemia 28:269–277CrossRefPubMed Chng WJ, Dispenzieri A, Chim CS et al (2014) IMWG consensus on risk stratification in multiple myeloma. Leukemia 28:269–277CrossRefPubMed
3.
Zurück zum Zitat Rajkumar SV (2013) Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88:226–235CrossRefPubMed Rajkumar SV (2013) Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88:226–235CrossRefPubMed
4.
Zurück zum Zitat Pratt G, Jenner M, Owen R et al (2014) Updates to the guidelines for the diagnosis and management of multiple myeloma. Br J Haematol 167:131–133CrossRefPubMed Pratt G, Jenner M, Owen R et al (2014) Updates to the guidelines for the diagnosis and management of multiple myeloma. Br J Haematol 167:131–133CrossRefPubMed
5.
Zurück zum Zitat Mikhael JR, Dingli D, Roy V et al (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88:360–376CrossRefPubMed Mikhael JR, Dingli D, Roy V et al (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88:360–376CrossRefPubMed
6.
Zurück zum Zitat Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176CrossRefPubMed Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176CrossRefPubMed
7.
Zurück zum Zitat Hose D, Moreaux J, Meissner T et al (2009) Induction of angiogenesis by normal and malignant plasma cells. Blood 114:128–143CrossRefPubMed Hose D, Moreaux J, Meissner T et al (2009) Induction of angiogenesis by normal and malignant plasma cells. Blood 114:128–143CrossRefPubMed
8.
Zurück zum Zitat Rajkumar SV, Leong T, Roche PC et al (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 6:3111–3116PubMed Rajkumar SV, Leong T, Roche PC et al (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 6:3111–3116PubMed
9.
Zurück zum Zitat Rajkumar SV, Mesa RA, Fonseca R et al (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8:2210–2216PubMed Rajkumar SV, Mesa RA, Fonseca R et al (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8:2210–2216PubMed
10.
Zurück zum Zitat Hillengass J, Zechmann C, Bauerle T et al (2009) Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation. Clin Cancer Res 15:3118–3125CrossRefPubMed Hillengass J, Zechmann C, Bauerle T et al (2009) Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation. Clin Cancer Res 15:3118–3125CrossRefPubMed
11.
Zurück zum Zitat Hillengass J, Wasser K, Delorme S et al (2007) Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res 13:475–481CrossRefPubMed Hillengass J, Wasser K, Delorme S et al (2007) Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res 13:475–481CrossRefPubMed
12.
Zurück zum Zitat Bhutani M, Turkbey B, Tan E et al (2014) Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia 28:413–416CrossRefPubMed Bhutani M, Turkbey B, Tan E et al (2014) Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia 28:413–416CrossRefPubMed
13.
Zurück zum Zitat Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol 82:1444–1452CrossRefPubMed Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol 82:1444–1452CrossRefPubMed
14.
Zurück zum Zitat Merz M, Ritsch J, Kunz C et al (2015) Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma. Clin Cancer Res 21:106–112CrossRefPubMed Merz M, Ritsch J, Kunz C et al (2015) Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma. Clin Cancer Res 21:106–112CrossRefPubMed
15.
Zurück zum Zitat Moehler TM, Hawighorst H, Neben K et al (2001) Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 93:862–868CrossRefPubMed Moehler TM, Hawighorst H, Neben K et al (2001) Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 93:862–868CrossRefPubMed
16.
Zurück zum Zitat Zwick S, Brix G, Tofts PS et al (2010) Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol 20:432–442CrossRefPubMed Zwick S, Brix G, Tofts PS et al (2010) Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol 20:432–442CrossRefPubMed
17.
Zurück zum Zitat Zamagni E, Cavo M (2012) The role of imaging techniques in the management of multiple myeloma. Br J Haematol 159:499–513PubMed Zamagni E, Cavo M (2012) The role of imaging techniques in the management of multiple myeloma. Br J Haematol 159:499–513PubMed
18.
Zurück zum Zitat Song MK, Chung JS, Lee JJ et al (2014) Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation. Br J Haematol 165:777–785CrossRefPubMed Song MK, Chung JS, Lee JJ et al (2014) Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation. Br J Haematol 165:777–785CrossRefPubMed
19.
Zurück zum Zitat Regelink JC, Minnema MC, Terpos E et al (2013) Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol 162:50–61CrossRefPubMed Regelink JC, Minnema MC, Terpos E et al (2013) Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol 162:50–61CrossRefPubMed
20.
Zurück zum Zitat Moulopoulos LA, Dimopoulos MA, Christoulas D et al (2010) Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents. Leukemia 24:1206–1212CrossRefPubMed Moulopoulos LA, Dimopoulos MA, Christoulas D et al (2010) Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents. Leukemia 24:1206–1212CrossRefPubMed
21.
Zurück zum Zitat Dutoit JC, Vanderkerken MA, Anthonissen J et al (2014) The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma. Eur Radiol 24:2754–2765CrossRefPubMed Dutoit JC, Vanderkerken MA, Anthonissen J et al (2014) The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma. Eur Radiol 24:2754–2765CrossRefPubMed
22.
Zurück zum Zitat Hillengass J, Zechmann CM, Nadler A et al (2008) Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma. Int J Cancer 122:2871–2875CrossRefPubMed Hillengass J, Zechmann CM, Nadler A et al (2008) Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma. Int J Cancer 122:2871–2875CrossRefPubMed
23.
Zurück zum Zitat Neben K, Jauch A, Hielscher T et al (2013) Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol 31:4325–4332CrossRefPubMed Neben K, Jauch A, Hielscher T et al (2013) Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol 31:4325–4332CrossRefPubMed
24.
Zurück zum Zitat Kumar S, Witzig TE, Timm M et al (2004) Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104:1159–1165CrossRefPubMed Kumar S, Witzig TE, Timm M et al (2004) Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104:1159–1165CrossRefPubMed
25.
Zurück zum Zitat Tanaka Y, Abe M, Hiasa M et al (2007) Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res 13:816–823CrossRefPubMed Tanaka Y, Abe M, Hiasa M et al (2007) Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res 13:816–823CrossRefPubMed
26.
Zurück zum Zitat Savvopoulou V, Maris TG, Vlahos L et al (2008) Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI). Eur Radiol 18:1876–1883CrossRefPubMed Savvopoulou V, Maris TG, Vlahos L et al (2008) Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI). Eur Radiol 18:1876–1883CrossRefPubMed
27.
Zurück zum Zitat Hillengass J, Stieltjes B, Bauerle T et al (2011) Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol 52:324–330CrossRefPubMed Hillengass J, Stieltjes B, Bauerle T et al (2011) Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol 52:324–330CrossRefPubMed
28.
Zurück zum Zitat Vogel MN, Weisel K, Maksimovic O et al (2009) Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease. AJR Am J Roentgenol 193:656–661CrossRefPubMed Vogel MN, Weisel K, Maksimovic O et al (2009) Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease. AJR Am J Roentgenol 193:656–661CrossRefPubMed
29.
Zurück zum Zitat Larocca A, Child JA, Cook G et al (2013) The impact of response on bone-directed therapy in patients with multiple myeloma. Blood 122:2974–2977CrossRefPubMed Larocca A, Child JA, Cook G et al (2013) The impact of response on bone-directed therapy in patients with multiple myeloma. Blood 122:2974–2977CrossRefPubMed
30.
Zurück zum Zitat Terpos E, Morgan G, Dimopoulos MA et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol 31:2347–2357CrossRefPubMed Terpos E, Morgan G, Dimopoulos MA et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol 31:2347–2357CrossRefPubMed
31.
Zurück zum Zitat Huang SY, Chen BB, Lu HY et al (2012) Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma. Am J Hematol 87:837–839CrossRefPubMed Huang SY, Chen BB, Lu HY et al (2012) Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma. Am J Hematol 87:837–839CrossRefPubMed
32.
Zurück zum Zitat Kumar S, Gertz MA, Dispenzieri A et al (2004) Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 34:235–239CrossRefPubMed Kumar S, Gertz MA, Dispenzieri A et al (2004) Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 34:235–239CrossRefPubMed
33.
Zurück zum Zitat Bhatti SS, Kumar L, Dinda AK et al (2006) Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters. Am J Hematol 81:649–656CrossRefPubMed Bhatti SS, Kumar L, Dinda AK et al (2006) Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters. Am J Hematol 81:649–656CrossRefPubMed
34.
Zurück zum Zitat Andrulis M, Bauerle T, Goldschmidt H et al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970–974CrossRefPubMed Andrulis M, Bauerle T, Goldschmidt H et al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970–974CrossRefPubMed
35.
Zurück zum Zitat Usmani SZ, Mitchell A, Waheed S et al (2013) Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. Blood 121:1819–1823CrossRefPubMedPubMedCentral Usmani SZ, Mitchell A, Waheed S et al (2013) Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. Blood 121:1819–1823CrossRefPubMedPubMedCentral
Metadaten
Titel
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study
verfasst von
Maximilian Merz
Thomas M. Moehler
Judith Ritsch
Tobias Bäuerle
Christian M. Zechmann
Barbara Wagner
Anna Jauch
Dirk Hose
Christina Kunz
Thomas Hielscher
Hendrik Laue
Hartmut Goldschmidt
Stefan Delorme
Jens Hillengass
Publikationsdatum
29.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3928-4

Weitere Artikel der Ausgabe 5/2016

European Radiology 5/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.